☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
AbbVie's Rinvoq (upadacitinib) Met Primary and Secondary Endpoints in P-III SELECT-AXIS 2 Clinical Trial for Non-Radiographic Axia...
October 8, 2021
Schr'dinger Signs a Two-Year Research Collaboration with MD Anderson to Advance its WEE1 Program
October 8, 2021
Sanofi Signs a Non-Exclusive Clinical Collaboration Agreement with Mirati to Evaluate Adagrasib + SAR442720 (RMC-4630) in P-I/II S...
October 8, 2021
Allogene Reports the US FDA's Clinical Hold on ALPHA2 Study of ALLO-501A to Treat Large B Cell Lymphoma
October 8, 2021
Takeda Receives the US FDA Advisory Committee's Recommendation for TAK-620 (maribavir) to Treat CMV Infection in Post-Transplant R...
October 8, 2021
AbbVie's Rinvoq (upadacitinib) Receives the Health Canada Approval for the Treatment of Moderate to Severe Atopic Dermatitis
October 8, 2021
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions